Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 5321-5330 of 11316

Edit search filters
  1. A Study to Compare Ridinilazole Versus Vancomycin Treatment for Clostridium Difficile Infection (CDI)

    Rochester, MN

  2. Prophylactic Benzodiazepine versus Reinstitution of Maintenance Antiseizure Drugs following Ictal SPECT

    Jacksonville, FL

  3. A Study to Assess Force Feedback with the SoftHand Pro

    Rochester, MN

  4. Intensive Parent-child Interaction Therapy (I-PCIT): Feasibility and Effectiveness Study.

    La Crosse, WI

  5. Study of Determine the Safety and Effectiveness of SHP647 as Maintenance Therapy in Subjects with Moderate-to-Severe Crohn's Disease

    La Crosse, WI

  6. Calcium and Magnesium in Preventing Peripheral Neuropathy Caused by Ixabepilone in Patients With Breast Cancer

    Rochester, MN

  7. Study of the Safety, Tolerability, Pharmacokinetics and Biomarker of DONQ52 in Celiac Disease Patients

    Rochester, MN

  8. Multicenter Study Evaluating Certolizumab Pegol Compared to Placebo in Subjects With axSpA Without X-ray Evidence of AS

    Rochester, MN

  9. PERT for Treatment of Exocrine Pancreatic Insufficiency in Patients With Unresectable Pancreatic Cancer

  10. A Study to Assess CSF1R-related Leukoencephalopathy After Stem Cell Transplantation

    Jacksonville, FL

.

Mayo Clinic Footer